Effectiveness of Using an Oil Bath Additive

March 7, 2017 updated by: PD Dr. Jan Kottner, Charite University, Berlin, Germany

Prospective, Randomized Study on the Skin Functional Parameters to Assess Skin Barrier Improvement After the Use of a Commercially Available Oil Bath Containing 84.75% Soybean Oil Compared to no Bath Additive

Epidermis that lacks moisture and/or sebum presents as dry skin, which is often characterized by a pattern of fine lines, scaling and itching. In dry skin, the barrier function may be compromised. Skin care practices to decrease the risk of development of dry skin and/or to improve dry skin condition have barely been investigated. Bathing with bath oils has been shown to increase skin hydration, thus helping to stabilize skin barrier function. Therefore, the aim of this study is to investigate the effect of bathing every other day on the skin barrier. Functional parameters, such as TEWL, stratum corneum hydration (SCH) and skin-pH (pH) were measured to characterize skin barrier function.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10117
        • Charite - Universitatsmedizin Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 85 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Signed informed consent, or children whose parent(s) or guardian(s) have given their written informed consent for their child's participation in the study
  • Child specific written informed consent, if over 7 years of age
  • Subjects with a general good and stable health condition
  • Subjects with clinically stable medical conditions
  • Accept to abstain from sunbathing and solarium during the study
  • Overall Dry Skin score (ODS) of 1 to 2 at arms and lower legs
  • TEWL > 12 g/m2/h on the left mid volar forearm

Exclusion Criteria:

  • Any dermatological condition or skin affection which may interfere with the study assessments, e.g. scars
  • Suffering from porphyria
  • Suffering from severe photodermatoses according to the judgment of the investigator
  • Clinically significant, possibly unstable medical conditions such as metastatic tumor
  • Currently having other malignant or benign tumors of the skin in the investigational area
  • Any other acute or chronic pathology that may interfere with the study conduct in the investigator's opinion
  • Known allergy or intolerance to any ingredients of the study product, e.g. propylene glycol
  • Use of (medical) oil-containing bath additives or other oil-containing cleansers
  • Current topical or systemic treatment affecting the skin, e.g. diuretics
  • Treatment of dry and/or inflammatory skin conditions with topical corticosteroids during the 4 weeks before inclusion
  • Systemic immunosuppressive or immunomodulatory therapy
  • Topical retinoids applied during the 6 weeks before inclusion
  • Topical application of immunosuppressive treatment during the 6 weeks before inclusion
  • Therapeutic UV-Radiation during the 6 weeks before inclusion
  • Increased UV-exposure during the 6 weeks before inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Balneum oil bath
Balneum oil bath, bathing every other day for four weeks
No Intervention: standard skin cleanser
Usual skin cleanser (non-oil containing), bathing or showering every other day for four weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
Time Frame: Day 28 +/- 3

TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h on the left midvolar forearm.

Visit 3 (day 28) - end of study visit

Day 28 +/- 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
Time Frame: Day 14 +/- 2

TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h on the left midvolar forearm.

Visit 2 (day14) - intermediate visit

Day 14 +/- 2
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2

TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h at the right lateral lower leg.

Visit 2 (day14)

Day 14 +/- 2
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3

TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h at the right lateral lower leg.

Visit 3 (day 28)

Day 28 +/- 3
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2

SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out.

Visit 2 (day 14)

Day 14 +/- 2
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3

SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher is SCH. Per investigational site three replicate measurements were carried out.

Visit 3 (day 28)

Day 28 +/- 3
Skin Surface Mean Roughness (Ra) in µm at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany). It consists of a UV light camera and measures the skin surface profiles. Ra=mean roughness
Day 14 +/- 2
Skin Surface Mean Roughness (Ra) in µm at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany). It consists of a UV light camera and measures the skin surface profiles. Ra=mean roughness
Day 28 +/- 3
Skin Surface Mean Roughness (Rz) in µm at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device. It consists of a UV light camera and measures the skin surface profiles. The parameter Rz was calculated. Rz=mean roughness of five equally spaced sampling lenghts.
Day 14 +/- 2
Skin Surface Mean Roughness (Rz) in µm at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device. It consists of a UV light camera and measures the skin surface profiles. The parameter Rz was calculated. Rz=mean roughness of five equally spaced sampling lenghts.
Day 28 +/- 3
Skin Surface pH at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003). The pH of the skin surface may differ from the pH of the stratum corneum. Means of triple measurements/images per skin area.
Day 14 +/- 2
Skin Surface pH at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003). The pH of the skin surface may differ from the pH of the stratum corneum. Means of triple measurements/images per skin area.
Day 28 +/- 3
Overall Dry Skin (ODS) Score at the Left Arm
Time Frame: Day 14 +/- 2

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day14) - intermediate visit

Day 14 +/- 2
Overall Dry Skin (ODS) Score at the Left Arm
Time Frame: Day 28 +/- 3

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness by the investigator using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks)

Day 28 +/- 3
Overall Dry Skin (ODS) Score at the Right Arm
Time Frame: Day 14 +/- 2

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day14)

Day 14 +/- 2
Overall Dry Skin (ODS) Score at the Right Arm
Time Frame: Day 28 +/- 3

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28)

Day 28 +/- 3
Overall Dry Skin (ODS) Score at the Left Lower Leg
Time Frame: Day 14 +/- 2

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14) - intermediate visit

Day 14 +/- 2
Overall Dry Skin (ODS) Score at the Left Lower Leg
Time Frame: Day 28 +/- 3

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) - end of study visit

Day 28 +/- 3
Overall Dry Skin (ODS) Score at the Right Lower Leg
Time Frame: Day 14 +/- 2

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14) - intermediate visit

Day 14 +/- 2
Overall Dry Skin (ODS) Score at the Right Lower Leg
Time Frame: Day 28 +/- 3

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28)

Day 28 +/- 3
Overall Dry Skin (ODS) Score at the Trunk
Time Frame: Day 14 +/- 2

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14)

Day 14 +/- 2
Overall Dry Skin (ODS) Score at the Trunk
Time Frame: Day 28 +/- 3

The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk.

(0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) - end of study visit

Day 28 +/- 3
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2

SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out.

Visit 2 (day 14)

Day 14 +/- 2
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3

SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out.

Visit 3 (day 28)

Day 28 +/- 3
Skin Surface Mean Roughness (Ra) in µm at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany). It consists of a UV light camera and measures the skin surface profiles. Ra=mean roughness
Day 14 +/- 2
Skin Surface Mean Roughness (Ra) in µm at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany). It consists of a UV light camera and measures the skin surface profiles. Ra=mean roughness
Day 28 +/- 3
Skin Surface Mean Roughness (Rz) in µm at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device. It consists of a UV light camera and measures the skin surface profiles. The parameter Rz was calculated. Rz=mean roughness of five equally spaced sampling lenghts.
Day 14 +/- 2
Skin Surface Mean Roughness (Rz) in µm at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device. It consists of a UV light camera and measures the skin surface profiles. The parameter Rz was calculated. Rz=mean roughness of five equally spaced sampling lenghts.
Day 28 +/- 3
Skin Surface pH at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003). The pH on the skin surface may differ from the pH of the stratum corneum. Means of triple measurements/images per skin area.
Day 14 +/- 2
Skin Surface pH at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003). The pH on the skin surface may differ from the pH of the stratum corneum. Means of triple measurements/images per skin area.
Day 28 +/- 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

September 21, 2015

First Submitted That Met QC Criteria

September 22, 2015

First Posted (Estimate)

September 23, 2015

Study Record Updates

Last Update Posted (Actual)

April 5, 2017

Last Update Submitted That Met QC Criteria

March 7, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CRC-SP-ABC-13

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Xerosis Cutis

Clinical Trials on Balneum oil bath

Subscribe